Related Experiment Video
Updated: Feb 11, 2026

Inducing the Entry of Third Stage Dispersal Juveniles of Bursaphelenchus xylophilus into Cryptobiosis Through Osmotic Regulation
Published on: December 27, 2024
Juvenile Scleroderma-What has Changed in the Meantime?
Amra Adrovic1, Sezgin Sahin1, Kenan Barut1
1Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.
Juvenile scleroderma, a rare connective tissue disease, presents systemic and localized forms. Current treatments combine disease-modifying anti-rheumatic drugs and steroids, with biologics showing promise for severe cases.
Area of Science:
- Pediatric Rheumatology
- Dermatology
- Connective Tissue Diseases
Background:
- Juvenile scleroderma is a rare chronic connective tissue disorder affecting children, characterized by skin stiffening.
- The disease occurs in approximately one in a million children and is classified into systemic and localized forms based on organ involvement.
- Systemic juvenile scleroderma involves skin, musculoskeletal, and vascular systems, with rare cardiovascular, gastrointestinal, and renal complications.
Purpose of the Study:
- To review recent findings and new developments in juvenile scleroderma due to its rarity and limited research.
- To provide an updated overview of systemic and localized juvenile scleroderma, including clinical features and therapeutic strategies.
Main Methods:
- A systematic literature search was conducted using PubMed/Medline and the Cochrane Library.
- The search focused on recent randomized controlled trials, case-control studies, cohort studies, and case reports concerning juvenile scleroderma.
- Both systemic and localized forms of the disease were included in the review.
Main Results:
- Systemic juvenile scleroderma primarily manifests with skin, musculoskeletal, and vascular issues; internal organ involvement is infrequent in children.
- First-line therapy for systemic juvenile scleroderma involves a combination of disease-modifying anti-rheumatic drugs (e.g., methotrexate, mycophenolate mofetil, cyclosporine) and steroids.
- Bosentan is utilized for pulmonary hypertension and digital ulcerations, while biological treatments offer options for severe disease; localized scleroderma lacks specific therapies.
Conclusions:
- Current understanding of juvenile scleroderma is often extrapolated from adult studies, highlighting a need for pediatric-specific research.
- Multicenter, prospective studies are crucial for clarifying the clinical course and prognosis of juvenile scleroderma.
- Genetic factors, particularly HLA class II, are implicated in pathogenesis, and emerging biological agents show therapeutic potential.
Related Concept Videos
Global Climate Change
Rates of Change
Work Done During Volume Change
Consider a gas confined to a cylinder fitted with a movable piston at one end. If the gas expands from volume V1 to volume V2, it exerts a force on the piston, such that the piston moves by a distance dr.
The work done by the gas on the piston can be expressed as
Le Chatelier's Principle: Changing Temperature
To understand this phenomenon, consider the elementary reaction:
Standard Entropy Change for a Reaction
Unsoundness of Aggregate due to Volume Change

